Screener
aTyr Pharma ATYR EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by aTyr Pharma in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: aTyr Pharma’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001339970-26-000053
FAQ
- What is aTyr Pharma's EPS (diluted)?
- aTyr Pharma (ATYR) reported EPS (diluted) of -$0.11 in Q2 2026.
- How has aTyr Pharma's EPS (diluted) changed year-over-year?
- aTyr Pharma's EPS (diluted) increased by 50.0% year-over-year, from -$0.22 to -$0.11.
- What is the long-term trend for aTyr Pharma's EPS (diluted)?
- Over 4 years (2021 to 2025), aTyr Pharma's EPS (diluted) has grown at a -18.4% compound annual growth rate (CAGR), from -$1.78 to -$0.79.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about aTyr Pharma's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude